Literature DB >> 21288817

Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.

Warren Phipps1, Misty Saracino, Amalia Magaret, Stacy Selke, Mike Remington, Meei-Li Huang, Terri Warren, Corey Casper, Lawrence Corey, Anna Wald.   

Abstract

BACKGROUND: Patients with newly acquired genital herpes simplex virus 2 (HSV-2) infection have virus frequently detected at the genital mucosa. Rates of genital shedding initially decrease over time after infection, but data on long-term viral shedding are lacking.
METHODS: For this study, 377 healthy adults with history of symptomatic genital HSV-2 infection collected anogenital swabs for HSV-2 DNA polymerase chain reaction for at least 30 consecutive days.
RESULTS: Time since first genital herpes episode was significantly associated with reduced genital shedding. Total HSV shedding occurred on 33.6% of days in participants <1 year, 20.6% in those 1-9 years, and 16.7% in those ≥10 years from first episode. Subclinical HSV shedding occurred on 26.2% of days among participants <1 year, 13.1% in those 1-9 years, and 9.3% in those ≥10 years from first episode. On days with HSV detection, mean quantity was 4.9 log₁₀ copies/mL for those <1 year, 4.7 log₁₀ copies/mL among those 1-9 years, and 4.6 log₁₀ copies/mL among those ≥10 years since first episode.
CONCLUSIONS: Rates of total and subclinical HSV-2 shedding decrease after the first year following the initial clinical episode. However, viral shedding persists at high rates and copy numbers years after infection, and therefore may pose continued risk of HSV-2 transmission to sexual partners.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21288817      PMCID: PMC3058740          DOI: 10.1093/infdis/jiq035

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

Review 1.  Pathogenesis of herpes simplex virus infection and animal models for its study.

Authors:  L R Stanberry
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

2.  Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples.

Authors:  D I Bernstein; M A Lovett; Y J Bryson
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

3.  Recurrent genital herpes simplex virus infection in guinea pigs.

Authors:  L R Stanberry; E R Kern; J T Richards; J C Overall
Journal:  Intervirology       Date:  1985       Impact factor: 1.763

4.  Virologic characteristics of subclinical and symptomatic genital herpes infections.

Authors:  A Wald; J Zeh; S Selke; R L Ashley; L Corey
Journal:  N Engl J Med       Date:  1995-09-21       Impact factor: 91.245

Review 5.  Herpes simplex virus type 2 transmission: risk factors and virus shedding.

Authors:  Anna Wald
Journal:  Herpes       Date:  2004-08

6.  Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Authors:  A Wald; J Zeh; G Barnum; L G Davis; L Corey
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

7.  Genital shedding of herpes simplex virus among men.

Authors:  Anna Wald; Judith Zeh; Stacy Selke; Terri Warren; Rhoda Ashley; Lawrence Corey
Journal:  J Infect Dis       Date:  2002-10-15       Impact factor: 5.226

8.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

Review 9.  Genital herpes simplex virus infections: clinical manifestations, course, and complications.

Authors:  L Corey; H G Adams; Z A Brown; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

10.  Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women.

Authors:  R W Cone; A C Hobson; Z Brown; R Ashley; S Berry; C Winter; L Corey
Journal:  JAMA       Date:  1994-09-14       Impact factor: 56.272

View more
  33 in total

1.  Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone.

Authors:  Sita Awasthi; John M Lubinski; Carolyn E Shaw; Shana M Barrett; Michael Cai; Fushan Wang; Michael Betts; Susan Kingsley; Daniel J Distefano; John W Balliet; Jessica A Flynn; Danilo R Casimiro; Janine T Bryan; Harvey M Friedman
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

2.  Viral kinetics of genital herpes: a molecular probe into host-viral interactions.

Authors:  Thomas C Quinn
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

3.  Herpes simplex virus genital infections: current concepts.

Authors:  Carolyn Gardella
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

4.  Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.

Authors:  Elfriede Agyemang; Amalia S Magaret; Stacy Selke; Christine Johnston; Larry Corey; Anna Wald
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

5.  Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.

Authors:  Warren Phipps; Edith Nakku-Joloba; Elizabeth M Krantz; Stacy Selke; Meei-Li Huang; Fred Kambugu; Jackson Orem; Corey Casper; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2015-10-20       Impact factor: 5.226

6.  Quantitative and qualitative correlates of cervicovaginal herpes simplex virus type 2 shedding among HIV-infected women in the Women's Interagency HIV Study.

Authors:  B Aumakhan; S J Gange; C Beyrer; C A Gaydos; H Minkoff; D J Merenstein; M H Cohen; K Anastos; R Greenblatt; M J Nowicki; T C Quinn
Journal:  Int J STD AIDS       Date:  2011-05       Impact factor: 1.359

7.  Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection.

Authors:  Elizabeth Tronstein; Christine Johnston; Meei-Li Huang; Stacy Selke; Amalia Magaret; Terri Warren; Lawrence Corey; Anna Wald
Journal:  JAMA       Date:  2011-04-13       Impact factor: 56.272

8.  The Effect of Hormonal Contraception and Menstrual Cycle Timing on Genital Herpes Simplex Virus-2 Shedding and Lesions.

Authors:  Elizabeth Micks; Hyunju Son; Amalia Magaret; Stacy Selke; Christine Johnston; Anna Wald
Journal:  Sex Transm Dis       Date:  2019-01       Impact factor: 2.830

9.  Theaflavin-3,3'-digallate and lactic acid combinations reduce herpes simplex virus infectivity.

Authors:  Charles E Isaacs; Weimin Xu
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

10.  Herpesvirus Infections and Risk of Frailty and Mortality in Older Women: Women's Health and Aging Studies.

Authors:  George C Wang; Christina Han; Barbara Detrick; Vincenzo Casolaro; David M Levine; Linda P Fried; Jeremy D Walston
Journal:  J Am Geriatr Soc       Date:  2016-04-30       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.